Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
65.975,11
-1,17%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Protara Therapeutics Inc (TARA) Protara Therapeutics Inc (TARA) Notizie

Protara Therapeutics Inc

TARA
2,60
-0,01 (-0,38%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:35:37
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:05EDGAR2Form 8-K - Current report
31/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202414:00GLOBEProtara Therapeutics to Present at the TD Cowen 5th Annual..
18/5/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
09/5/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202414:00GLOBEProtara Therapeutics Announces First Quarter 2024 Financial..
05/4/202414:04GLOBEProtara Therapeutics Announces Oversubscribed $45 Million..
05/4/202414:02GLOBEProtara Therapeutics Announces Alignment with FDA on..
05/4/202414:00GLOBEProtara Therapeutics Announces Positive Three-Month Data..
13/3/202413:00GLOBEProtara Therapeutics Announces Fourth Quarter and Full Year..
28/2/202414:00GLOBEProtara Therapeutics to Present at the TD Cowen 44th Annual..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202314:30GLOBEProtara Therapeutics Announces Presentation of Additional..
03/11/202313:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/11/202313:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202313:10EDGAR2Form 8-K - Current report
03/11/202313:00GLOBEProtara Therapeutics Announces Third Quarter 2023 Financial..
23/10/202314:00GLOBEProtara Therapeutics Announces Dosing of First Patient in..
20/9/202314:30GLOBEProtara Therapeutics Announces Dosing of First Patient in..
05/9/202313:30GLOBEProtara Therapeutics to Present at the H.C. Wainwright 25th..
03/8/202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:12EDGAR2Form 8-K - Current report
03/8/202314:00GLOBEProtara Therapeutics Announces Second Quarter 2023 Financial..
18/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,61 Min: 2,50 Max: 2,65
Chiusura: 2,61

La tua Cronologia

NASDAQ
TARA
Protara Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network